Compare DSX & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSX | ORGO |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | Greece | United States |
| Employees | 939 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.5M | 348.6M |
| IPO Year | N/A | 2016 |
| Metric | DSX | ORGO |
|---|---|---|
| Price | $2.67 | $2.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 580.8K | ★ 1.3M |
| Earning Date | 05-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | $14.28 | N/A |
| Revenue Next Year | $4.87 | $26.27 |
| P/E Ratio | $16.02 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $1.38 | $2.04 |
| 52 Week High | $2.92 | $7.08 |
| Indicator | DSX | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 52.36 | 47.20 |
| Support Level | $1.63 | $2.21 |
| Resistance Level | $2.72 | $2.63 |
| Average True Range (ATR) | 0.11 | 0.20 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 42.99 | 51.68 |
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.